vinpocetine has been researched along with Cognition Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliev, KT; Lalayan, TV; Pugachova, EL; Skoromets, AA; Smolko, DG | 1 |
| Konchugova, TV; Orekhova, EM; Prikazchikova, OA; Raĭgorodskiĭ, IuM; Svistunov, AA | 1 |
| Bedi, KL; Deshmukh, R; Mehan, S; Sharma, N; Sharma, V | 1 |
| Lobzin, VIu; Odinak, MM | 1 |
| Antipenko, EA; Davydova, TA; Emelin, AIu; Fedorova, IaB; Gavrilova, SI; Gustov, AV; Kalyn, IaB; Kashin, AV; Kolykhalov, IV; Korshunova, IuA; Messler, G; Odinak, MM; Roshchina, IF; Selezneva, ND | 1 |
| Balogh, A; Fehér, G; Késmárky, G; Misnyovszky, M; Nagy, K; Németh, G; Németh, GY; Szapáry, L; Tóth, K; Tóth, T | 1 |
| Szatmari, SZ; Whitehouse, PJ | 1 |
| Valikovics, A | 1 |
| Kidd, PM | 1 |
| Horváth, S | 1 |
| Astengo, F; Balestreri, R; Fontana, L | 1 |
4 review(s) available for vinpocetine and Cognition Disorders
| Article | Year |
|---|---|
[Vinpocetin in neurological diseases].
Topics: Animals; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition; Cognition Disorders; Dementia, Vascular; Hemorheology; Humans; Microcirculation; Nervous System Diseases; Neuroprotective Agents; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2012 |
Vinpocetine for cognitive impairment and dementia.
Topics: Alzheimer Disease; Cognition Disorders; Dementia; Dementia, Vascular; Humans; Nootropic Agents; Randomized Controlled Trials as Topic; Vinca Alkaloids | 2003 |
A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
Topics: Acetylcarnitine; Cognition Disorders; Complementary Therapies; Dementia; Ginkgo biloba; Humans; Nootropic Agents; Phosphatidylserines; Phytotherapy; Plant Extracts; Plants, Medicinal; Risk Factors; Vinca Alkaloids | 1999 |
[The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
Topics: Calcium Channel Blockers; Cerebrovascular Circulation; Chronic Disease; Clinical Trials as Topic; Cognition; Cognition Disorders; Germany; Humans; Hypoxia, Brain; Italy; Japan; Memory; Memory Disorders; Neuroprotective Agents; Nootropic Agents; Severity of Illness Index; Sodium Channels; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2001 |
5 trial(s) available for vinpocetine and Cognition Disorders
| Article | Year |
|---|---|
[Cognitive functions and treatment of their impairment in elderly patients with the vertebrobasilar issufficiensy].
Topics: Aged; Cognition Disorders; Female; Humans; Male; Middle Aged; Neurologic Examination; Neuroprotective Agents; Treatment Outcome; Vasodilator Agents; Vertebrobasilar Insufficiency; Vinca Alkaloids | 2013 |
[Efficacy of dynamic magnetic therapy in the complex treatment of cognitive disturbances in patients with chronic cerebrovascular insufficiency].
Topics: Aged; Antihypertensive Agents; Brain; Cerebrovascular Disorders; Cognition Disorders; Female; Humans; Magnetic Field Therapy; Male; Middle Aged; Treatment Outcome; Vinca Alkaloids | 2009 |
[Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive imp
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Amino Acids; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Syndrome; Time Factors; Treatment Outcome; Vinca Alkaloids | 2010 |
[Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Topics: Administration, Oral; Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dementia, Vascular; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Nootropic Agents; Pilot Projects; Psychometrics; Severity of Illness Index; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 2007 |
A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction.
Topics: Aged; Aged, 80 and over; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Placebos; Time Factors; Vasodilator Agents; Vinca Alkaloids | 1987 |
2 other study(ies) available for vinpocetine and Cognition Disorders
| Article | Year |
|---|---|
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Cerebral Ventricles; Cognition Disorders; Glutathione; L-Lactate Dehydrogenase; Male; Malondialdehyde; Maze Learning; Memory; Motor Activity; Nitrites; Oxidative Stress; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Streptozocin; Vinca Alkaloids | 2009 |
[The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Nootropic Agents; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 2009 |